Skip to content

The RECOGNISE Study: Neuropsychological Rehabilitation for Emotional and Cognitive consequences After Neurovascular Diseases

The RECOGNISE study: Rehabilitation of Emotional and Cognitive Outcomes through Guided Neuropsychological Intervention, promoting Self-Efficacy after neurovascular diseases - The RECOGNISE study: neuropsychological rehabilitation for emotional and cognitive consequences after neurovascular conditions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57539
Enrollment
30
Registered
2025-05-16
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular accidents, subarachnoid hemorrhage, arteriovenous malformations, cerebral small vessel disease, intracranial hemorrhage, cerebral amyloid angiopathy

Interventions

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, patients must meet the following criteria:Neuropsychological assessment (NPA) must reveal either cognitive impairments or subjective cognitive complaints, along with difficulties in managing these disorders/complaints, reintegrating into daily life, or maintaining other daily functions. These patients do not qualify for standard post-acute rehabilitation due to the lack of overt neurological deficits or formal cognitive impairments, yet they require targeted intervention to address the cognitive and emotional challenges that hinder their ability to return to work, social roles, and independent living.Sufficient understanding of the Dutch language to follow and comprehend the intervention sessions. Age 18 years or older.

Exclusion criteria

Exclusion criteria: Current severe psychiatric conditions or comorbidity with other neurological diseases that may interfere with the intervention.

Design outcomes

Primary

MeasureTime frame
Primary outcome: Change in self-efficacy scores from baseline to follow-up.

Secondary

MeasureTime frame
Secondary outcomes: Changes in QoL, daily participation, emotional well-being (e.g., depression, anxiety), and cognitive complaints over the study period.

Countries

Netherlands

Contacts

Public ContactS Khosdelazad

Universitair Medisch Centrum Groningen

s.khosdelazad@umcg.nl0503614817

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)